Shareholder Alert: Ademi LLP investigates whether Asensus Surgical, Inc. has obtained a Fair Price for its Public Shareholders
Wisconsin Eagle/10273316

MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Asensus Surgical (NYSE: ASXC) for possible breaches of fiduciary duty and other violations of law in its transaction with KARL STORZ

Click here to learn how to join the investigation: https://www.ademilaw.com/case/asensus-surgical-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

In the transaction, Asensus Surgical shareholders will receive only $0.35 per share in cash. The transaction agreement unreasonably limits competing transactions for Asensus Surgical by imposing a significant penalty if Asensus Surgical accepts a competing bid. Asensus Surgical insiders will receive substantial benefits as part of change of control arrangements.

More on Wisconsin Eagle

• Wohler announces release of additional Balance Control output tracking for its eSeries in-rack monitor range
• A Milestone of Giving: Ten Percent Group Donates £25,000 to Cure Parkinson's
• Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
• Swidget Launches Luminance™ to Help Schools Achieve Alyssa's Law Compliance
• Growing Demand for EVA Mats Signals Shift in Car Interior Market

We are investigating the conduct of Asensus Surgical's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Asensus Surgical common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/asensus-surgical-inc.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi LLP

---

Show All News | Report Violation